Macrogenics, Inc. · NASDAQ:MGNX
Armistice Capital, LLC reported a 9.99% stake in Macrogenics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 9.99% stake in Macrogenics, Inc., 6,324,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 6,324,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 6,324,000 |
| Steven Boyd | 9.99% | 6,324,000 |
Source
Related
- Macrogenics, Inc.
- Armistice Capital, LLC
- Macrogenics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Form 4 · Bonvini Ezio · Oct 7, 2026
- Form 4 · Peters Jeffrey Stuart · Aug 20, 2026
- Form 4 · Bonvini Ezio · Aug 18, 2026
- Schedule 13G/A · Bank of America Corp · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026